These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 36043390)
1. Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles. Mohammad Gholinia Sarpoli L; Zare-Karizi S; Heidari E; Hasanzadeh A; Bayandori M; Azedi F; Hamblin MR; Karimi M Pharm Dev Technol; 2022 Sep; 27(7):785-793. PubMed ID: 36043390 [TBL] [Abstract][Full Text] [Related]
2. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells. Su WP; Cheng FY; Shieh DB; Yeh CS; Su WC Int J Nanomedicine; 2012; 7():4269-83. PubMed ID: 22904633 [TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy. Wang S; Zhang J; Wang Y; Chen M Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968 [TBL] [Abstract][Full Text] [Related]
4. Polymeric nanoparticles for siRNA delivery and gene silencing. Patil Y; Panyam J Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242 [TBL] [Abstract][Full Text] [Related]
5. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging. Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307 [TBL] [Abstract][Full Text] [Related]
6. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells. Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799 [TBL] [Abstract][Full Text] [Related]
7. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells. Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829 [TBL] [Abstract][Full Text] [Related]
8. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer. Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759 [TBL] [Abstract][Full Text] [Related]
9. Co-delivery of Doxorubicin Encapsulated PLGA Nanoparticles and Bcl-xL shRNA Using Alkyl-Modified PEI into Breast Cancer Cells. Ebrahimian M; Taghavi S; Mokhtarzadeh A; Ramezani M; Hashemi M Appl Biochem Biotechnol; 2017 Sep; 183(1):126-136. PubMed ID: 28236188 [TBL] [Abstract][Full Text] [Related]
10. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model. Ben David-Naim M; Grad E; Aizik G; Nordling-David MM; Moshel O; Granot Z; Golomb G Biomaterials; 2017 Nov; 145():154-167. PubMed ID: 28863309 [TBL] [Abstract][Full Text] [Related]
11. Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A). Khan MN; Haggag YA; Lane ME; McCarron PA; Tambuwala MM Curr Drug Deliv; 2018 Feb; 15(2):286-295. PubMed ID: 29065834 [TBL] [Abstract][Full Text] [Related]
12. Development of modular polymeric nanoparticles for drug delivery using amine reactive chemistry. Wong C; Ho EA J Pharm Pharm Sci; 2024; 27():13148. PubMed ID: 39165831 [TBL] [Abstract][Full Text] [Related]
13. Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation. Vakilinezhad MA; Amini A; Dara T; Alipour S Colloids Surf B Biointerfaces; 2019 Dec; 184():110515. PubMed ID: 31585308 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity. Arvas B; Ucar B; Acar T; Varli HS; Arvas MB; Aydogan F; Yolacan C Nanotechnology; 2024 May; 35(30):. PubMed ID: 38636487 [TBL] [Abstract][Full Text] [Related]
15. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells. Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid). Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829 [TBL] [Abstract][Full Text] [Related]
17. Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency. Pantazis P; Dimas K; Wyche JH; Anant S; Houchen CW; Panyam J; Ramanujam RP Methods Mol Biol; 2012; 906():311-9. PubMed ID: 22791444 [TBL] [Abstract][Full Text] [Related]
18. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. Katas H; Cevher E; Alpar HO Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405 [TBL] [Abstract][Full Text] [Related]
19. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer. Mukerjee A; Ranjan AP; Vishwanatha JK J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of cellular uptake and cytotoxicity of curcumin-loaded PLGA nanoparticles by conjugation with anti-P-glycoprotein in drug resistance cancer cells. Punfa W; Yodkeeree S; Pitchakarn P; Ampasavate C; Limtrakul P Acta Pharmacol Sin; 2012 Jun; 33(6):823-31. PubMed ID: 22580738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]